fda drug shortages semaglutide injection status resolved 2025 As of February 21, 2025, the updated its shortage list, marking the shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Compounded Semaglutide & Tirzepatide 2025:

They are not medications, nor are they intended to diagnose, treat, prevent, or cure any disease or medical condition

Sabatino, engaging in a detailed discussion to understand each patients unique needs

FDA encourages health care providers and compounders to provide patients with the appropriate syringe size for the intended dose and counsel patients on how to measure the intended dose using the syringe, the agency said

Semaglutide 3 mg tablet compatibility with other medications Make sure to inform your doctor about all medications you're taking, including prescriptions, over-the-counter drugs, nutritional supplements, and herbal products